Clinical Trials Directory

Trials / Completed

CompletedNCT00854724

Puerarin Effects on Alcohol Drinking

Puerarin (NPI-031G) Effects on Alcohol Drinking - A Natural Settings Study

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Mclean Hospital · Academic / Other
Sex
All
Age
21 Years – 45 Years
Healthy volunteers
Accepted

Summary

This research is designed to assess the impact of pretreatment with puerarin (NPI-031G), a major ingredient in the plant kudzu, on alcohol drinking. Hypothesis: Short-term treatment with this compound will reduce alcohol self-administration in a simulated natural settings laboratory.

Detailed description

Participants will have an opportunity to drink up to 6 beers, plus water and juice, during a 90 minute afternoon drinking session in our simulated apartment room laboratory. Drinking sessions will be conducted in the afternoon after participants take puerarin or placebo for 7 days.

Conditions

Interventions

TypeNameDescription
DRUGPuerarin, Placebo400 mg, three times a day for 7 days

Timeline

Start date
2009-02-01
Primary completion
2011-03-01
Completion
2011-07-01
First posted
2009-03-03
Last updated
2011-09-09
Results posted
2011-08-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00854724. Inclusion in this directory is not an endorsement.

Puerarin Effects on Alcohol Drinking (NCT00854724) · Clinical Trials Directory